136 related articles for article (PubMed ID: 26935389)
1. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.
Wu Y; Liu C; Yu S; Gao H; Li Z; Li C; Zhang Y
Oncol Rep; 2016 May; 35(5):2991-9. PubMed ID: 26935389
[TBL] [Abstract][Full Text] [Related]
2. Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.
Wu Y; Bai J; Li Z; Wang F; Cao L; Liu C; Yu S; Yu G; Zhang Y
Pituitary; 2015 Jun; 18(3):335-42. PubMed ID: 24917361
[TBL] [Abstract][Full Text] [Related]
3. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
Shirian FI; Ghorbani M; Khamseh ME; Imani M; Panahi M; Alimohammadi A; Nourbakhsh M; Salimi V; Tavakoli-Yaraki M
BMC Endocr Disord; 2021 Mar; 21(1):50. PubMed ID: 33736633
[TBL] [Abstract][Full Text] [Related]
6. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
[TBL] [Abstract][Full Text] [Related]
7. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
9. EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.
Wang J; Liu Q; Gao H; Wan D; Li C; Li Z; Zhang Y
Tumour Biol; 2017 Jul; 39(7):1010428317706203. PubMed ID: 28705113
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.
Sun B; Liu X; Yang Y; Dai C; Li Y; Jiao Y; Wei Z; Yao Y; Feng M; Bao X; Deng K; Wang N; Wang R
J Mol Neurosci; 2016 Jan; 58(1):137-44. PubMed ID: 26676407
[TBL] [Abstract][Full Text] [Related]
11. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
12. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
[TBL] [Abstract][Full Text] [Related]
13. Expression of Cyclin E/Cdk2/p27
Dong W; Zhu H; Gao H; Shi W; Zhang Y; Wang H; Li C; Song G; Zhang Y
World Neurosurg; 2019 Jan; 121():e45-e53. PubMed ID: 30196178
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of microRNAs in GH-secreting pituitary adenomas.
Mao ZG; He DS; Zhou J; Yao B; Xiao WW; Chen CH; Zhu YH; Wang HJ
Diagn Pathol; 2010 Dec; 5():79. PubMed ID: 21138567
[TBL] [Abstract][Full Text] [Related]
15. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-secreting adenomas: pathology and cell biology.
Lopes MB
Neurosurg Focus; 2010 Oct; 29(4):E2. PubMed ID: 20887127
[TBL] [Abstract][Full Text] [Related]
17. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
18. Monomorphous Plurihormonal Pituitary Adenoma of Pit-1 Lineage in a Giant Adolescent with Central Hyperthyroidism.
Pereira BD; Raimundo L; Mete O; Oliveira A; Portugal J; Asa SL
Endocr Pathol; 2016 Mar; 27(1):25-33. PubMed ID: 26330191
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.
Fusco A; Zatelli MC; Bianchi A; Cimino V; Tilaro L; Veltri F; Angelini F; Lauriola L; Vellone V; Doglietto F; Ambrosio MR; Maira G; Giustina A; degli Uberti EC; Pontecorvi A; De Marinis L
J Clin Endocrinol Metab; 2008 Jul; 93(7):2746-50. PubMed ID: 18460561
[TBL] [Abstract][Full Text] [Related]
20. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]